BRAIN Biotech AG (BNN.DE) XETRA
Currency In EUR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 47.63M |
| Enterprise Value | 65.47M |
| P/E Ratio | -4.29 |
| PEG Ratio | 0.17 |
| Price/Sales Ratio | 1.05 |
| Price/Book Ratio | -8.68 |
| Enterprise/Revenue | 1.03 |
| Enterprise/EBITDA | -10.69 |
Fiscal Year
| Fiscal Year | September 30, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -0.25 |
| Operating Margin | -0.17 |
AD
Management Effectiveness
| Return On Assets | -0.25 |
| Return On Equity | 5.91 |
Income Statement
| Revenue | 49.62M |
| Revenue/Share | 2.7 |
| Gross Profit | 2.01M |
| EBITDA | -4.17M |
| Net Income | -11.74M |
| Diluted EPS | -0.54 |
Balance Sheet
| Total Cash | 940,000 |
| Total Cash/Share | 0.04 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 1.34 |
| Book Value Per Share | -0.33 |
Price History
| 52-Week Change | 25.22 |
| 52-Week High | 3.89 |
| 52-Week Low | 2.11 |
| Moving Average 50 Days | 2.78 |
| Moving Average 200 Days | 2.69 |
Statistics
| Average Volume | 5,072 |
| Shares Outstanding | 21.85M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
